TM6SF2 and metabolic dysfunction-associated steatotic liver disease: Recently, Gellert-Kristensen et al. showed that a genetic risk score (GRS) incorporating the NAFLD risk-modifying alleles in PNPLA3, TM6SF2 and HSD17B13 was significantly associated with cirrhosis [16].